European Medicines Agency Accepts Titan Pharmaceuticals' Marketing Authorization Application For Probuphine® November 27, 2017
Titan Pharmaceuticals Schedules Conference Call To Review Third Quarter 2017 Financial Results November 3, 2017
Titan Pharmaceuticals Presents Non-Clinical Data From Liothyronine (L-T3) Implant Studies October 19, 2017
First Patient Treated With Titan Pharmaceuticals' Subdermal Implant For Parkinson's Disease October 11, 2017
Titan Pharmaceuticals and Opiant Pharmaceuticals Collaborate to Explore a New Approach to Opioid Use Disorder Treatment October 2, 2017
Titan Pharmaceuticals To Present At Cantor Fitzgerald Global Healthcare Conference September 20, 2017
Titan Pharmaceuticals Receives FDA Clearance To Begin Clinical Study Of Parkinson's Disease Treatment August 24, 2017
